Breast cancer metastasis suppressor 1 coordinately regulates metastasis-associated microRNA expression

Mick D Edmonds1, Douglas R Hurst, Kedar S Vaidya

  • 1Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294-0019, USA.

Insights

Breast cancer metastasis suppressor 1 (BRMS1) regulates microRNA (miRNA) expression to inhibit cancer spread. BRMS1 decreases metastasis-promoting miRNAs and increases metastasis-suppressing miRNAs, impacting tumor progression.

Area of Science:

  • Molecular oncology
  • Cancer epigenetics
  • RNA biology

Background:

  • Breast cancer metastasis suppressor 1 (BRMS1) is a known inhibitor of metastasis in various cancers.
  • BRMS1 functions by forming complexes with SIN3 and histone deacetylases to alter gene expression.
  • MicroRNAs (miRNAs) are regulatory RNAs implicated in cancer progression.

Purpose of the Study:

  • To investigate whether BRMS1 exerts its antimetastatic effects by regulating miRNA expression.
  • To identify specific miRNAs regulated by BRMS1 in breast cancer cells.

Main Methods:

  • Comparative microRNA array analysis of metastatic and nonmetastatic breast cancer cell lines (MDA-MB-231, MDA-MB-435) with and without BRMS1 transfection.
  • Validation of differentially expressed miRNAs using SYBR Green RT-PCR.

Main Results:

  • BRMS1 transfection led to decreased expression of metastasis-promoting miRNAs (e.g., miR-10b, -373, -520c) and their downstream targets (e.g., RhoC).
  • BRMS1 transfection resulted in increased expression of metastasis-suppressing miRNAs (e.g., miR-146a, -146b, -335).

Conclusions:

  • BRMS1 coordinately regulates the expression of multiple metastasis-associated miRNAs.
  • BRMS1's regulation of miRNA expression is a key mechanism contributing to its antimetastatic activity.
  • BRMS1-containing SIN3:HDAC complexes may be recruited to miRNA promoters to modulate cancer metastasis.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...